124 related articles for article (PubMed ID: 11876993)
61. Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T(H)1 T cells.
Dietz AB; Litzow MR; Bulur PA; Vuk-Pavlović S
Cytotherapy; 2001; 3(2):97-105. PubMed ID: 12028832
[TBL] [Abstract][Full Text] [Related]
62. The role of autologous natural killer cells in chronic myelogenous leukemia.
Pierson BA; Miller JS
Leuk Lymphoma; 1997 Nov; 27(5-6):387-99. PubMed ID: 9477121
[TBL] [Abstract][Full Text] [Related]
63. Generation of V α13/β21+T cell specific target CML cells by TCR gene transfer.
Zha X; Xu L; Chen S; Yang L; Zhang Y; Lu Y; Yu Z; Li B; Wu X; Zheng W; Li Y
Oncotarget; 2016 Dec; 7(51):84246-84257. PubMed ID: 27713165
[TBL] [Abstract][Full Text] [Related]
64. Role of interferon-alpha and clonally expanded T cells in the immunotherapy of chronic myelogenous leukemia.
Fujii S
Leuk Lymphoma; 2000 Jun; 38(1-2):21-38. PubMed ID: 10811445
[TBL] [Abstract][Full Text] [Related]
65. Antitumor activity in vitro in chronic myelogenous leukaemia revealed after treating peripheral cells with cytosine arabinoside.
Pawelec G; Schmidt H; Rehbein A; Busch F
Cancer Immunol Immunother; 1989; 29(4):242-6. PubMed ID: 2526681
[TBL] [Abstract][Full Text] [Related]
66. The preparation of leukemia cell vaccine expressing BCG heat shock protein 70 and anti-leukemia effect in vitro.
Li XL; Sun LR; Wang Z; Sun XF
Int Immunopharmacol; 2012 Nov; 14(3):235-42. PubMed ID: 22892217
[TBL] [Abstract][Full Text] [Related]
67. gammadelta T cells lyse autologous and allogenic oesophageal tumours: involvement of heat-shock proteins in the tumour cell lysis.
Thomas ML; Samant UC; Deshpande RK; Chiplunkar SV
Cancer Immunol Immunother; 2000 Feb; 48(11):653-9. PubMed ID: 10663613
[TBL] [Abstract][Full Text] [Related]
68. [Autologous tumor killing (ATK) and tumor metastasis in human cancer patients].
Uchida A; Kariya Y
Hum Cell; 1993 Mar; 6(1):15-20. PubMed ID: 8343445
[TBL] [Abstract][Full Text] [Related]
69. Cellular immune responses to autologous chronic myelogenous leukaemia cells in vitro.
Pawelec G; Rehbein A; Schlotz E; da Silva P
Cancer Immunol Immunother; 1996 Mar; 42(3):193-9. PubMed ID: 8640848
[TBL] [Abstract][Full Text] [Related]
70. Chronic phase CML patients possess T cells capable of recognising autologous tumour cells.
Müller L; Pawelec G
Leuk Lymphoma; 2002 May; 43(5):943-51. PubMed ID: 12148904
[TBL] [Abstract][Full Text] [Related]
71. Clinical significance of autologous tumor killing (ATK) activity and its induction therapy in human cancer.
Uchida A
Biotherapy; 1994; 8(2):113-22. PubMed ID: 8924352
[TBL] [Abstract][Full Text] [Related]
72. Cytokine enhancement of immunogenicity in chronic myeloid leukaemia.
Coleman S; Throp D; Fisher J; Bailey-Wood R; Lim SH
Leukemia; 1997 Dec; 11(12):2055-9. PubMed ID: 9447820
[TBL] [Abstract][Full Text] [Related]
73. Transient 40 °C-shock potentiates cytotoxic responses of Vδ2
Lin L; Chen Y; Chen D; Shu J; Hu Y; Yin Z; Wu Y
Cancer Immunol Immunother; 2022 Oct; 71(10):2391-2404. PubMed ID: 35195762
[TBL] [Abstract][Full Text] [Related]
74. Heat shock-enhanced T cell apoptosis with heat shock protein 70 on T cell surface in multicentric Castleman's disease.
Ishiyama T; Koike M; Akimoto Y; Fukuchi K; Watanabe K; Yoshida M; Wakabayashi Y; Tsuruoka N
Clin Exp Immunol; 1996 Nov; 106(2):351-6. PubMed ID: 8918584
[TBL] [Abstract][Full Text] [Related]
75. Membrane HSP70: the molecule triggering gammadelta T cells in the early stage of tumorigenesis.
Zhang H; Hu H; Jiang X; He H; Cui L; He W
Immunol Invest; 2005; 34(4):453-68. PubMed ID: 16302688
[TBL] [Abstract][Full Text] [Related]
76. Functional and antigenic properties of cultured T cells in the cell mediated lympholysis (CML) assay.
Zier KS
Hum Immunol; 1982 Apr; 4(2):147-56. PubMed ID: 6978875
[TBL] [Abstract][Full Text] [Related]
77. Human TCRγδ+ T cells represent a novel target for IL-27 activity.
Morandi F; Prigione I; Airoldi I
Eur J Immunol; 2012 Jun; 42(6):1547-52. PubMed ID: 22678908
[TBL] [Abstract][Full Text] [Related]
78. Does Parkinson's disease have an immunological basis? The evidence and its therapeutic implications.
Fiszer U
BioDrugs; 2001; 15(6):351-5. PubMed ID: 11520246
[TBL] [Abstract][Full Text] [Related]
79. Biological significance of autologous tumor killing.
Uchida A; Kariya Y; Inoue N; Okamoto N; Sugie K
Immunol Ser; 1994; 61():195-206. PubMed ID: 8011744
[No Abstract] [Full Text] [Related]
80. Lymphocytotoxins in infectious mononucleosis: a non-cytotoxic effect on lymphocytes at 37 degrees C and the influence of cell metabolism on their cytotoxicity in vitro.
Quin JW; Charlesworth JA; Yasmeen D; Macdonald GJ; Pussell BA
Clin Exp Immunol; 1981 Feb; 43(2):285-90. PubMed ID: 7273482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
